A photo of Russel Hirsch.

Russel Hirsch, MD


  • Director, Pulmonary Hypertension Service
  • Professor, UC Department of Pediatrics
  • Board Certified

About

Location

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Cost-Utility of Sildenafil for Persistent Pulmonary Hypertension of the Newborn. Evers, PD; Critser, PJ; Cash, M; Magness, M; Hoelle, S; Hirsch, R. American Journal of Perinatology. 2021; 38:1505-1512.

The Fontan Pathway: Change in Dimension and Catheter-Based Intervention over Time. McGovern, E; Alsaied, T; Szugye, N; Pradhan, S; Batlivala, SP; Lubert, A; Hirsch, R. Pediatric Cardiology. 2021; 42:1740-1748.

ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening. Griffiths, M; Yang, J; Nies, M; Damico, RL; Ivy, DD; Martin, W; Nichols, B; Pauciulo, M; Everett, AD. (2021) 160:297-306.

Pulmonary vein stenosis: Treatment and challenges. Vanderlaan, RD; Rome, J; Hirsch, R; Ivy, D; Caldarone, CA. Journal of Thoracic and Cardiovascular Surgery. 2021; 161:2169-2176.

Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance. Thangappan, K; Morales, DL S; Vu, Q; Lehenbauer, D; Villa, C; Wittekind, S; Hirsch, R; Lorts, A; Zafar, F. Artificial Organs. 2021; 45:29-37.

Prognostic Value of Change in Cardiac Index After Prostacyclin Initiation in Pediatric Pulmonary Hypertension. Evers, PD; Critser, PJ; Cash, M; Magness, M; Hirsch, R. Pediatric Cardiology. 2021; 42:116-122.

Cardiovascular magnetic resonance imaging derived septal curvature in neonates with bronchopulmonary dysplasia associated pulmonary hypertension. Critser, PJ; Higano, NS; Lang, SM; Kingma, PS; Fleck, RJ; Hirsch, R; Taylor, MD; Woods, JC. Journal of Cardiovascular Magnetic Resonance. 2020; 22.

Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival. Griffiths, M; Yang, J; Nies, M; Vaidya, D; Brandal, S; Williams, M; Matsui, EC; Grant, T; Damico, R; Ivy, D; et al. Pediatric Research. 2020; 88:850-856.

Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry. Fakhri, S; Hannon, K; Moulden, K; Peterson, R; Hountras, P; Bull, T; Maloney, J; De Marco, T; Ivy, D; Thenappan, T; et al. Pulmonary Circulation. 2020; 10.

Balloon atrial septostomy as initial therapy in pediatric pulmonary hypertension. Critser, PJ; Evers, PD; McGovern, E; Cash, M; Hirsch, R. Pulmonary Circulation. 2020; 10.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey